183 related articles for article (PubMed ID: 37533611)
1. Cancer Therapy-Related Cardiotoxicity: A Comprehensive Retrospective Analysis at Najran Cancer Center, Saudi Arabia.
Badheeb AM; Ahmed F; Alzahrani HA; Badheeb MA; Obied HY; Seada IA
Cureus; 2023 Jul; 15(7):e41287. PubMed ID: 37533611
[TBL] [Abstract][Full Text] [Related]
2. Cardiotoxicity in Cancer Patients: The Prevalence, Risk Factors, and Cardioprotective Measures in a Cancer Centre in Saudi Arabia.
Badheeb AM; Alhosni Y; Alshahrani M; Asery TA; Al Nasher SM; Seada IA; Nasher AM; Alotaibi BA; Alsaaed E; Alsalem AM; Abu Bakar A; Alselwi W; Ahmed F; Alyami NH; Bin Dahman L; Badheeb M; Obied HY
Cureus; 2024 May; 16(5):e59608. PubMed ID: 38832203
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular end-diastolic volume as early indicator of trastuzumab-related cardiotoxicity in HER2+ breast cancer patients: results from a single-center retrospective study.
Bergamini C; Torelli F; Ghiselli L; Rossi A; Trevisani L; Vinco G; Truong S; Benfari G; LA Russa F; Golia G; Molino A; Vassanelli C
Minerva Cardioangiol; 2017 Jun; 65(3):278-287. PubMed ID: 27886160
[TBL] [Abstract][Full Text] [Related]
4. Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study.
Moey MYY; Liles DK; Carabello BA
Cardiooncology; 2019; 5():9. PubMed ID: 32154015
[TBL] [Abstract][Full Text] [Related]
5. Effect of obesity, dyslipidemia, and diabetes on trastuzumab-related cardiotoxicity in breast cancer.
Kosalka P; Johnson C; Turek M; Sulpher J; Law A; Botros J; Dent S; Aseyev O
Curr Oncol; 2019 Jun; 26(3):e314-e321. PubMed ID: 31285674
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Depression and Anxiety Symptoms Among Patients With Cancer in Najran, Saudi Arabia.
Ghowinam MA; Albokhari AA; Badheeb AM; Lamlom M; Alwadai M; Hamza A; Aladalah A
Cureus; 2024 Feb; 16(2):e54349. PubMed ID: 38500908
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity with adjuvant trastuzumab use in breast cancer: A single institution's experience.
Aldiab A
J Saudi Heart Assoc; 2010 Jul; 22(3):133-6. PubMed ID: 23960606
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors Associated with Trastuzumab-induced Cardiotoxicity in Patients with Human Epidermal Growth Factor Receptor 2-positive Breast Cancer.
Abdel-Razaq W; Alzahrani M; Al Yami M; Almugibl F; Almotham M; Alregaibah R
J Pharm Bioallied Sci; 2019; 11(4):348-354. PubMed ID: 31619917
[TBL] [Abstract][Full Text] [Related]
9. Association of Neurohormonal Antagonists on Incident Cardiotoxicity in Patients With Breast Cancer.
Umadat G; Ray J; Cornell L; Pillai D; Gharacholou SM
Am J Cardiol; 2023 Feb; 188():68-79. PubMed ID: 36473307
[TBL] [Abstract][Full Text] [Related]
10. Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs.
Ho CC; Wen PC; Yu WC; Hu YW; Yang CC
J Chin Med Assoc; 2021 Sep; 84(9):877-884. PubMed ID: 34320515
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients.
Henry ML; Niu J; Zhang N; Giordano SH; Chavez-MacGregor M
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1084-1093. PubMed ID: 30092967
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Therapeutic Characteristics of Hospitalized Patients with Advanced Lung Cancer in Najran, Saudi Arabia: A Retrospective Study.
Badheeb AM; Obied HY; Al Suleiman M; Qurayshah MA; Awad MA; Abu Bakar A; Alwadai B; Nasher AM; Seada IA; Alyami NH; Aman AA; Ahmed F; Al Qasim A; Badheeb M
Cureus; 2024 Apr; 16(4):e58602. PubMed ID: 38770472
[TBL] [Abstract][Full Text] [Related]
13. Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study.
Kaboré EG; Guenancia C; Vaz-Luis I; Di Meglio A; Pistilli B; Coutant C; Cottu P; Lesur A; Petit T; Dalenc F; Rouanet P; Arnaud A; Arsene O; Ibrahim M; Wassermann J; Boileau-Jolimoy G; Martin AL; Lemonnier J; André F; Arveux P
PLoS Med; 2019 Dec; 16(12):e1002989. PubMed ID: 31869400
[TBL] [Abstract][Full Text] [Related]
14. Trastuzumab-induced cardiotoxicity and its risk factors in real-world setting of breast cancer patients.
Moilanen T; Jokimäki A; Tenhunen O; Koivunen JP
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1613-1621. PubMed ID: 29872916
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab cardiotoxicity in HER2-positive breast cancer patients in tertiary health care center, sultanate of Oman.
Alghafar DA; Younos I; Baimani KA; Al-Salhi D; Al-Riyami A; Rizvi S; Buckley NE
J Oncol Pharm Pract; 2021 Mar; 27(2):312-321. PubMed ID: 32340535
[TBL] [Abstract][Full Text] [Related]
16. Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of Anticancer Treatment-Induced Cardiotoxicity in Non-Small-Cell Lung Cancer: A Real-World Study.
Kobat H; Elkonaissi I; Foreman E; Davidson M; Idaikkadar P; O'Brien M; Nabhani-Gebara S
Clin Lung Cancer; 2024 Jan; 25(1):e35-e42. PubMed ID: 37880075
[TBL] [Abstract][Full Text] [Related]
17. Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity.
Čiburienė E; Aidietienė S; Ščerbickaitė G; Brasiūnienė B; Drobnienė M; Baltruškevičienė E; Žvirblis T; Čelutkienė J
J Cardiovasc Dev Dis; 2022 Apr; 9(5):. PubMed ID: 35621845
[TBL] [Abstract][Full Text] [Related]
18. Cardio-oncology in Austria: cardiotoxicity and surveillance of anti-cancer therapies : Position paper of the Heart Failure Working Group of the Austrian Society of Cardiology.
Bergler-Klein J; Rainer PP; Wallner M; Zaruba MM; Dörler J; Böhmer A; Buchacher T; Frey M; Adlbrecht C; Bartsch R; Gyöngyösi M; Fürst UM
Wien Klin Wochenschr; 2022 Sep; 134(17-18):654-674. PubMed ID: 35507087
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials.
Keshavarzian E; Sadighpour T; Mortazavizadeh SM; Soltani M; Motevalipoor AF; Khamas SS; Moazen M; Kogani M; Amin Hashemipour SM; Hosseinpour H; Valizadeh R
Rev Recent Clin Trials; 2023; 18(2):112-122. PubMed ID: 36803186
[TBL] [Abstract][Full Text] [Related]
20. Lisinopril or Coreg CR in reducing cardiotoxicity in women with breast cancer receiving trastuzumab: A rationale and design of a randomized clinical trial.
Guglin M; Munster P; Fink A; Krischer J
Am Heart J; 2017 Jun; 188():87-92. PubMed ID: 28577685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
